Australia markets closed

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
933.50-25.95 (-2.70%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 965.53B
Enterprise value 947.28B
Trailing P/E 32.85
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.25
Price/book (mrq)5.15
Enterprise value/revenue 5.12
Enterprise value/EBITDA 20.80

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 385.69%
S&P500 52-week change 325.01%
52-week high 31,031.70
52-week low 3484.95
50-day moving average 3961.28
200-day moving average 3729.05

Share statistics

Avg vol (3-month) 31.31M
Avg vol (10-day) 31.4M
Shares outstanding 51.01B
Implied shares outstanding 61.01B
Float 8250.74M
% held by insiders 175.13%
% held by institutions 114.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46
Forward annual dividend yield 40.63%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.83
Payout ratio 420.54%
Dividend date 3N/A
Ex-dividend date 428 July 2023
Last split factor 25:1
Last split date 306 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 15.63%
Operating margin (ttm)19.69%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)190.24B
Revenue per share (ttm)187.97
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)29.56B
Diluted EPS (ttm)29.17
Quarterly earnings growth (yoy)26.80%

Balance sheet

Total cash (mrq)15.19B
Total cash per share (mrq)15.01
Total debt (mrq)1.92B
Total debt/equity (mrq)0.92%
Current ratio (mrq)N/A
Book value per share (mrq)185.06

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A